About The Study: This randomized clinical trial found that treatment with abatacept, cenicriviroc, or infliximab showed no significant difference of time to recovery compared with placebo for patients hospitalized with COVID-19 pneumonia. Authors: William G. Powderly, M.D., of the Washington University School of Medicine in St. Louis, is the corresponding author. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jama.2023.110

https://www.miragenews.com/abatacept-cenicriviroc-or-infliximab-for-adults-1043903/

#miragenews